McKesson Company Profile (NYSE:MCK)

About McKesson

McKesson logoMcKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs Wholesale
  • Sub-Industry: Health Care Distributors
  • Exchange: NYSE
  • Symbol: MCK
  • CUSIP: 58155Q10
Key Metrics:
  • Previous Close: $148.97
  • 50 Day Moving Average: $144.83
  • 200 Day Moving Average: $155.81
  • 52-Week Range: $114.53 - $199.43
  • Trailing P/E Ratio: 17.90
  • Foreward P/E Ratio: 12.66
  • P/E Growth: 1.51
  • Market Cap: $31.99B
  • Outstanding Shares: 212,052,000
  • Beta: 1.06
  • Net Margins: 0.97%
  • Return on Equity: 30.05%
  • Return on Assets: 4.69%
  • Debt-to-Equity Ratio: 0.76%
  • Current Ratio: 1.03%
  • Quick Ratio: 0.61%
Additional Links:
Companies Related to McKesson:

Analyst Ratings

Consensus Ratings for McKesson (NYSE:MCK) (?)
Ratings Breakdown: 1 Sell Rating, 10 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $176.14 (16.77% upside)

Analysts' Ratings History for McKesson (NYSE:MCK)
DateFirmActionRatingPrice TargetDetails
1/21/2017Leerink SwannSet Price TargetHold$155.00View Rating Details
1/18/2017Avondale PartnersUpgradeMarket Perform -> Outperform$157.00 -> $193.00View Rating Details
1/5/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$171.00 -> $169.00View Rating Details
1/3/2017MizuhoDowngradeBuy -> Neutral$147.00View Rating Details
11/23/2016Credit Suisse GroupDowngradeNeutral -> Underperform$150.00 -> $131.00View Rating Details
11/11/2016Standpoint ResearchDowngradeBuy -> HoldView Rating Details
10/28/2016Deutsche Bank AGDowngradeBuy -> Hold$196.00 -> $153.00View Rating Details
10/28/2016Robert W. BairdDowngradeOutperform -> Neutral$200.00 -> $164.00View Rating Details
9/19/2016ArgusReiterated RatingHoldView Rating Details
9/16/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$210.00 -> $189.00View Rating Details
7/28/2016Morgan StanleyBoost Price TargetOverweight$199.00 -> $211.00View Rating Details
7/28/2016Citigroup Inc.Boost Price TargetBuy$215.00 -> $225.00View Rating Details
6/30/2016Bank of America CorpReiterated RatingHoldView Rating Details
6/29/2016FBR & CoReiterated RatingBuy$210.00View Rating Details
6/1/2016Raymond James Financial, Inc.DowngradeStrong-Buy -> OutperformView Rating Details
3/15/2016Cowen and CompanyDowngradeOutperform -> Market Perform$208.00 -> $173.00View Rating Details
3/11/2016Royal Bank of CanadaReiterated RatingBuyView Rating Details
1/15/2016Barclays PLCReiterated RatingOverweight$220.00 -> $211.00View Rating Details
7/31/2015S&P Equity ResearchReiterated RatingBuy$268.00View Rating Details
(Data available from 2/25/2015 forward)


Earnings History for McKesson (NYSE:MCK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016Q217$3.05$2.94$24.16 billion$49.96 billionViewListenView Earnings Details
7/27/2016Q117$3.33$3.50$50.32 billion$49.73 billionViewListenView Earnings Details
5/4/2016Q416$3.14$2.44$46.83 billion$46.68 billionViewN/AView Earnings Details
1/27/2016Q316$3.13$3.18$48.97 billion$47.90 billionViewListenView Earnings Details
10/29/2015Q216$2.99$3.31$47.85 billion$48.60 billionViewListenView Earnings Details
7/29/2015Q116$2.91$3.14$46.02 billion$47.50 billionViewListenView Earnings Details
5/12/2015Q415$2.75$2.94$45.00 billion$44.93 billionViewListenView Earnings Details
2/5/2015Q315$2.61$2.89$44.81 billion$47.01 billionViewN/AView Earnings Details
10/28/2014Q215$2.73$2.79$42.99 billion$44.76 billionViewN/AView Earnings Details
7/31/2014Q115$2.36$2.49$40.65 billion$44.06 billionViewN/AView Earnings Details
5/12/2014Q414$2.40$2.55$35.89 billion$38.14 billionViewN/AView Earnings Details
1/31/2014Q314$1.85$1.45$38.57 billion$34.30 billionViewN/AView Earnings Details
10/24/2013Q214$2.03$2.27$32.16 billion$33.00 billionViewListenView Earnings Details
7/25/2013Q1 2014$1.71$2.07$32.60 billion$32.20 billionViewListenView Earnings Details
5/7/2013Q4 2013$2.30$1.45$32.01 billion$30.62 billionViewListenView Earnings Details
1/31/2013Q3 2013$1.62$1.41$30.81 billion$31.19 billionViewListenView Earnings Details
10/25/2012$1.78$1.92ViewN/AView Earnings Details
7/26/2012$1.48$1.55ViewN/AView Earnings Details
4/30/2012$2.04$2.09ViewN/AView Earnings Details
1/30/2012$1.38$1.40ViewN/AView Earnings Details
10/25/2011$1.38$1.63ViewN/AView Earnings Details
7/28/2011$1.10$1.27ViewN/AView Earnings Details
5/3/2011$1.60$1.66ViewN/AView Earnings Details
1/31/2011$1.12$1.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for McKesson (NYSE:MCK)
Current Year EPS Consensus Estimate: $12.69 EPS
Next Year EPS Consensus Estimate: $11.92 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$3.12$3.34$3.19
Q2 20163$3.20$3.47$3.33
Q3 20163$3.40$3.52$3.47
Q4 20162$3.76$3.79$3.78
Q1 20172$3.36$3.40$3.38
Q2 20172$3.10$3.10$3.10
Q3 20172$2.85$3.46$3.16
Q4 20172$3.14$3.51$3.33
Q1 20181$2.92$2.92$2.92
Q2 20181$2.96$2.96$2.96
Q3 20181$2.95$2.95$2.95
Q4 20181$3.07$3.07$3.07
(Data provided by Zacks Investment Research)


Current Dividend Information for McKesson (NYSE:MCK)
Annual Dividend:$1.12
Dividend Yield:0.74%
Dividend Growth:10.10% (3 Year Average)
Payout Ratio:13.25% (Based on Trailing 12 Months of Earnings)
8.83% (Based on Current Year Consensus EPS Estimate)
9.40% (Based on Next Year Consensus EPS Estimate)
Track Record:4 Years of Consecutive Dividend Growth

Dividend History for McKesson (NYSE:MCK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for McKesson (NYSE:MCK)
Insider Ownership Percentage: 1.15%
Institutional Ownership Percentage: 87.81%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/5/2016Wayne A. BuddDirectorSell723$145.77$105,391.71View SEC Filing  
11/30/2016Lori A SchechterEVPBuy692$144.52$100,007.84View SEC Filing  
11/2/2016Susan R SalkaDirectorBuy1,000$136.35$136,350.00View SEC Filing  
10/31/2016Erin M LampertSVPSell921$123.99$114,194.79View SEC Filing  
10/3/2016Erin M. LampertSVPSell1,739$165.94$288,569.66View SEC Filing  
9/12/2016John H HammergrenChairmanSell100,500$180.77$18,167,385.00View SEC Filing  
9/12/2016Wayne A BuddDirectorSell2,309$179.70$414,927.30View SEC Filing  
9/6/2016John H HammergrenChairmanSell100,500$184.22$18,514,110.00View SEC Filing  
8/22/2016M Christine JacobsDirectorSell915$193.78$177,308.70View SEC Filing  
8/1/2016Marie L/Ca KnowlesDirectorSell915$192.73$176,347.95View SEC Filing  
7/14/2016James A BeerCFOSell5,500$199.00$1,094,500.00View SEC Filing  
5/25/2016John H HammergrenCEOSell37,420$182.87$6,842,995.40View SEC Filing  
5/25/2016Patrick BlakeEVPSell6,322$182.87$1,156,104.14View SEC Filing  
5/24/2016John H HammergrenCEOSell18,709$182.06$3,406,160.54View SEC Filing  
5/24/2016Lori A SchechterEVPSell107$182.06$19,480.42View SEC Filing  
5/23/2016John H HammergrenCEOSell18,718$179.33$3,356,698.94View SEC Filing  
5/23/2016Patrick BlakeEVPSell3,162$179.33$567,041.46View SEC Filing  
5/10/2016John H HammergrenCEOSell101,833$170.71$17,383,911.43View SEC Filing  
4/25/2016John H HammergrenCEOSell101,833$176.81$18,005,092.73View SEC Filing  
4/4/2016John H HammergrenCEOSell45,300$159.00$7,202,700.00View SEC Filing  
3/15/2016Nigel A ReesSVPSell6,000$157.59$945,540.00View SEC Filing  
2/2/2016Susan R SalkaDirectorBuy1,000$156.21$156,210.00View SEC Filing  
2/1/2016Lori A. SchechterEVPSell2,476$159.73$395,491.48View SEC Filing  
1/4/2016John H. HammergrenCEOSell101,833$194.11$19,766,803.63View SEC Filing  
12/1/2015John H. HammergrenCEOSell101,833$190.06$19,354,379.98View SEC Filing  
11/24/2015John H. HammergrenCEOSell56,533$190.01$10,741,835.33View SEC Filing  
10/12/2015John H. HammergrenCEOSell101,835$190.51$19,400,585.85View SEC Filing  
8/13/2015Paul C JulianEVPSell55,666$214.54$11,942,583.64View SEC Filing  
7/15/2015Paul C JulianEVPSell27,833$234.04$6,514,035.32View SEC Filing  
7/14/2015Paul C JulianEVPSell27,833$232.86$6,481,192.38View SEC Filing  
6/17/2015Paul C JulianEVPSell55,668$234.06$13,029,652.08View SEC Filing  
5/28/2015John H HammergrenCEOSell60,000$238.53$14,311,800.00View SEC Filing  
5/28/2015Lori A SchechterEVPSell1,468$238.22$349,706.96View SEC Filing  
5/26/2015John H HammergrenCEOSell30,062$238.97$7,183,916.14View SEC Filing  
5/26/2015Paul C JulianEVPSell15,289$238.97$3,653,612.33View SEC Filing  
5/22/2015Jorge FigueredoEVPSell20,775$240.11$4,988,285.25View SEC Filing  
5/15/2015Jorge FigueredoEVPSell8,525$240.00$2,046,000.00View SEC Filing  
2/17/2015Randall N SprattEVPSell44,523$225.00$10,017,675.00View SEC Filing  
2/12/2015Randall N SprattEVPSell7,477$225.00$1,682,325.00View SEC Filing  
2/10/2015Alton F Irby IIIDirectorSell5,000$220.76$1,103,800.00View SEC Filing  
2/10/2015Nigel A ReesMajor ShareholderSell9,000$220.42$1,983,780.00View SEC Filing  
1/28/2015John H HammergrenCEOSell64,521$219.52$14,163,649.92View SEC Filing  
1/26/2015Brian Scott TylerEVPSell5,431$216.62$1,176,463.22View SEC Filing  
1/26/2015John H HammergrenCEOSell35,479$219.07$7,772,384.53View SEC Filing  
1/7/2015John H HammergrenCEOSell77,100$214.00$16,499,400.00View SEC Filing  
12/8/2014John H HammergrenCEOSell12,200$214.01$2,610,922.00View SEC Filing  
11/28/2014Patrick BlakeEVPSell19,000$210.00$3,990,000.00View SEC Filing  
11/24/2014John H HammergrenCEOSell100,000$209.25$20,925,000.00View SEC Filing  
11/12/2014Paul C JulianEVPSell74,666$202.51$15,120,611.66View SEC Filing  
10/31/2014Patrick BlakeEVPSell38,000$204.68$7,777,840.00View SEC Filing  
10/8/2014Paul C JulianEVPSell74,667$195.86$14,624,278.62View SEC Filing  
10/7/2014John H HammergrenCEOSell100,000$197.28$19,728,000.00View SEC Filing  
9/10/2014Paul C JulianEVPSell74,667$196.76$14,691,478.92View SEC Filing  
8/29/2014Jorge FigueredoEVPSell24,500$195.00$4,777,500.00View SEC Filing  
8/8/2014M Christine JacobsDirectorSell2,619$189.88$497,295.72View SEC Filing  
8/5/2014Marie L/Ca KnowlesDirectorSell785$192.10$150,798.50View SEC Filing  
6/2/2014Patrick BlakeEVPSell15,000$190.00$2,850,000.00View SEC Filing  
5/29/2014Paul C JulianEVPSell21,057$186.89$3,935,342.73View SEC Filing  
5/28/2014Alton F Irby IIIDirectorSell4,000$182.73$730,920.00View SEC Filing  
5/28/2014John H HammergrenCEOSell125,596$183.31$23,023,002.76View SEC Filing  
5/28/2014Jorge FigueredoEVPSell20,542$183.30$3,765,348.60View SEC Filing  
5/27/2014Brian Scott TylerEVPSell3,916$183.30$717,802.80View SEC Filing  
5/22/2014Brian Scott TylerEVPSell8,250$184.17$1,519,402.50View SEC Filing  
3/21/2014Jorge FigueredoEVPSell23,684$185.81$4,400,724.04View SEC Filing  
3/10/2014Patrick BlakeEVPSell38,750$180.36$6,988,950.00View SEC Filing  
2/4/2014Brian Scott TylerEVPSell6,250$169.68$1,060,500.00View SEC Filing  
1/22/2014Alton Irby IIIDirectorSell1,300$167.98$218,374.00View SEC Filing  
11/1/2013Nigel A ReesCFOSell7,000$158.72$1,111,040.00View SEC Filing  
10/29/2013Brian Scott TylerEVPSell8,250$153.44$1,265,880.00View SEC Filing  
10/11/2013Brian Scott TylerEVPSell9,000$138.51$1,246,590.00View SEC Filing  
10/9/2013Paul JulianEVPSell84,000$134.04$11,259,360.00View SEC Filing  
10/8/2013Brian Scott TylerEVPSell9,000$138.00$1,242,000.00View SEC Filing  
9/11/2013Paul C JulianEVPSell84,000$126.20$10,600,800.00View SEC Filing  
8/7/2013Paul JulianEVPSell84,000$123.29$10,356,360.00View SEC Filing  
8/6/2013Marie L/Ca KnowlesDirectorSell1,223$123.54$151,089.42View SEC Filing  
7/30/2013Brian Scott TylerEVPSell6,250$123.94$774,625.00View SEC Filing  
6/19/2013Paul C JulianEVPSell84,750$114.89$9,736,927.50View SEC Filing  
6/14/2013David M LawrenceDirectorSell7,500$114.28$857,100.00View SEC Filing  
6/14/2013Jorge FigueredoEVPSell6,250$115.00$718,750.00View SEC Filing  
6/10/2013Jorge FigueredoEVPSell10,000$115.00$1,150,000.00View SEC Filing  
6/4/2013Jorge FigueredoEVPSell22,500$113.63$2,556,675.00View SEC Filing  
5/30/2013Laureen SeegerEVPSell57,750$114.89$6,634,897.50View SEC Filing  
5/29/2013John H HammergrenCEOSell230,484$115.21$26,554,061.64View SEC Filing  
5/29/2013Randall N SprattEVPSell32,226$115.21$3,712,757.46View SEC Filing  
5/28/2013Brian Scott TylerEVPSell6,023$116.33$700,655.59View SEC Filing  
5/28/2013Jeffrey C CampbellCFOSell73,102$116.33$8,503,955.66View SEC Filing  
5/24/2013Laureen SeegerEVPSell17,250$116.50$2,009,625.00View SEC Filing  
5/22/2013Laureen SeegerEVPSell17,250$118.13$2,037,742.50View SEC Filing  
5/20/2013Brian Scott TylerEVPSell5,000$117.81$589,050.00View SEC Filing  
5/15/2013Nigel A ReesVPSell8,000$116.00$928,000.00View SEC Filing  
5/10/2013Brian Scott TylerEVPSell6,250$115.59$722,437.50View SEC Filing  
5/10/2013John H HammergrenCEOSell75,000$115.30$8,647,500.00View SEC Filing  
1/18/2013Jorge FigueredoEVPSell2,500$103.22$258,050.00View SEC Filing  
1/17/2013Laureen SeegerEVPSell17,250$103.00$1,776,750.00View SEC Filing  
9/4/2012Paul C JulianEVPSell36,250$87.02$3,154,475.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for McKesson (NYSE:MCK)
News IconBarack Obama Takes Daughter Malia to Broadway Show — And He Looks Incredible! (NYSE:MCK) - February 25 at 12:42 AM
News IconDrug firms want case moved to fed court (NYSE:MCK) - February 25 at 12:42 AM
News IconFebruary 24 Market Close: GovCon Index Up, Records 4th Straight Weekly Gain - GovConWire (NYSE:MCK) - February 24 at 7:41 PM logoMcKesson Corporation (MCK) Ex-Dividend Date Scheduled for February 27, 2017 - Nasdaq (NYSE:MCK) - February 24 at 9:34 AM
News IconStiff penalties put pressure on drug distributors (NYSE:MCK) - February 23 at 11:31 PM
News IconMcKesson, National Decision Support Company launch partnership (NYSE:MCK) - February 23 at 11:31 PM logoMcKesson : Radiology Named 2017 Category Leader for PACS Community Hospital (NYSE:MCK) - February 23 at 11:31 PM logoMcKesson Corporation (NYSE:MCK) Investor Lawsuit against certain Directors filed (NYSE:MCK) - February 23 at 11:31 PM
News IconMckesson actonel discount card - Actonel once a week tablets - Buy actonel drug (NYSE:MCK) - February 23 at 11:31 PM
News IconHealthcare RCM, Patient Collections Solutions Launch at HIMSS17 (NYSE:MCK) - February 23 at 6:30 PM
News IconAddressing hope, frustration and value-based uncertainty at HIMSS (NYSE:MCK) - February 23 at 6:30 PM logoEclipse Corporation Acquires DocOrigin Enterprise Document Software Intellectual Property (NYSE:MCK) - February 23 at 6:30 PM logoMcKesson : University of Wisconsin Puts FHIR to Work (NYSE:MCK) - February 23 at 6:30 PM logoEx-Dividend Reminder: McKesson Corp, Universal Health Services and Nelnet (NYSE:MCK) - February 23 at 6:30 PM logoUniversity of Wisconsin Puts FHIR to Work (NYSE:MCK) - February 23 at 6:30 PM
News IconGlobal Healthcare Information Software Industry 2017-2022 Valid Results, Clinical Healthcare Solutions & Market Applications: Cerner, McKesson (NYSE:MCK) - February 23 at 7:01 AM
News Iconcialis 10 mg cost (NYSE:MCK) - February 23 at 7:01 AM
News IconFebruary 22 Market Close: GovCon Index Flat, S&P 500 Dips After Fed Minutes (NYSE:MCK) - February 22 at 6:35 PM
News IconSmyrna home brims with creativity (NYSE:MCK) - February 22 at 6:35 PM logoGlobal Famotidine Injection Market 2017: Medline Industries, Mylan, Ciron Pharma, McKesson Pharma, Allegiance Health (NYSE:MCK) - February 22 at 6:35 PM
News IconInnovaccer Launched Comprehensive Platform to Optimise the 7 Stages of VBR at HIMSS 2017 - Datashop (NYSE:MCK) - February 22 at 6:35 PM
News IconNDSC partners with McKesson, Meditech (NYSE:MCK) - February 22 at 8:15 AM
News IconClinical Data Analytics Market 2017 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2020 (NYSE:MCK) - February 22 at 8:15 AM
News IconStories in America: DeRay Mckesson Talks Education and Social Change at AU (NYSE:MCK) - February 22 at 8:15 AM logoClinical Data Analytics Market to Reach $16.98 billion with 41.50% CAGR Forecast to 2020 (NYSE:MCK) - February 22 at 8:15 AM
News IconDrugs Wholesale: McKesson Corporation (NYSE:MCK) Position of the day (NYSE:MCK) - February 22 at 8:15 AM logoBuying McKesson At A 10% Yield (NYSE:MCK) - February 22 at 8:15 AM
News IconMcKesson Reinventing Revenue Cycle Management for a Value-Based World (NYSE:MCK) - February 21 at 6:27 PM
News IconAnalytical Guide for Ameren Corporation (AEE), McKesson Corporation (MCK) Stakeholders - The USA Commerce (NYSE:MCK) - February 20 at 10:12 AM
News IconLookout for Price Target? Dr Pepper Snapple Group, Inc. (DPS), McKesson Corporation (MCK) - StockNewsJournal (NYSE:MCK) - February 19 at 9:58 AM
News IconGlobal Healthcare Mobile Computers Market Analysis and Forecast 2022 by Product, End user and Region (NYSE:MCK) - February 18 at 8:40 AM
News IconHow Have McKesson Corporation (NYSE:MCK) Earnings Outlook Changed? (NYSE:MCK) - February 17 at 7:34 PM logoForm 8-A12B MCKESSON CORP (NYSE:MCK) - February 17 at 7:34 PM
News Icon$150 Million Settlement over a False Claims Act Allegations against McKesson Corporation announced by ... - GroundReport (NYSE:MCK) - February 17 at 2:33 PM
News IconTraders Secrets on McKesson Corporation (MCK), Celgene Corporation (CELG) - StockNewsJournal (NYSE:MCK) - February 17 at 2:33 PM logoForm 8-A12B MCKESSON CORP - (NYSE:MCK) - February 17 at 2:33 PM logoMCKESSON CORP Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance She (NYSE:MCK) - February 17 at 2:33 PM logo3 Great Stocks on Sale (NYSE:MCK) - February 17 at 2:33 PM logoMcKesson Radiology Named 2017 Category Leader for PACS (Community Hospital) (NYSE:MCK) - February 16 at 6:04 PM
News IconMcKesson Corporation EUR600m 0.625% Aug 21, EUR600m 1.5% Aug 25 and GBP450m 3.125% Feb 29 (NYSE:MCK) - February 16 at 6:04 PM logoMcKesson Corp. breached its 50 day moving average in a Bullish Manner : MCK-US : February 15, 2017 (NYSE:MCK) - February 16 at 6:03 PM
News IconFebruary 14 Market Close: GovCon Index Lifted By McKesson Surge, US Stocks Set New Record Highs on Apple & Banks (NYSE:MCK) - February 14 at 7:59 PM logoMcKesson : Wake County EMS Selects McKesson (NYSE:MCK) - February 14 at 7:59 PM
News IconNYSE:MCK Investor Alert: Lawsuit filed against certain Directors of McKesson Corporation (NYSE:MCK) - February 14 at 7:59 PM logoWake County EMS Selects McKesson (NYSE:MCK) - February 14 at 7:59 PM
News IconCity of Welch suing drug companies over opioids (NYSE:MCK) - February 14 at 5:40 AM logoFitch Rates McKesson's EUR and GBP Notes 'BBB+'; Outlook Stable (NYSE:MCK) - February 14 at 12:38 AM
News IconShout-Out: Covington Wins Trade Secrets Trial with $500M on the Line (NYSE:MCK) - February 14 at 12:38 AM logoNJ Whistleblower Denied Shares Of States' FCA Settlements (NYSE:MCK) - February 13 at 7:36 PM logoMoody's Assigns Baa2 to McKesson's new Euro and GBP Notes (NYSE:MCK) - February 13 at 7:36 PM


What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Wednesday, January 25th. Investors of record on Wednesday, March 1st will be paid a dividend of $0.28 per share on Monday, April 3rd. This represents a $1.12 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend is Monday, February 27th.

Where is McKesson's stock going? Where will McKesson's stock price be in 2017?

17 analysts have issued twelve-month price objectives for McKesson's shares. Their predictions range from $131.00 to $225.00. On average, they anticipate McKesson's stock price to reach $176.14 in the next twelve months.

When will McKesson announce their earnings?

McKesson is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.

What are analysts saying about McKesson stock?

Here are some recent quotes from research analysts about McKesson stock:

  • According to Zacks Investment Research, "McKesson depends heavily on the pharmaceutical distribution business, which is characterized by slow growth. Unfavorable movements in foreign exchange rates continue to hurt sales. In addition McKesson expects weaker generic pharmaceutical pricing trends, specific to the company’s mix of business, in 2017. Moreover, the expiration of McKesson’s contract with Optum will be a major headwind. Operating performance of Celesio which was disappointing in the fiscal first quarter of 2017 due to reimbursement cuts, is expected to continue through the year. However, the company has been actively pursuing deals and acquisitions to drive growth. McKesson will separate its Technology business into a new healthcare information technology company, which is slated to close in the first half of calendar 2017. The spin-off will enable the company to concentrate on the primary pharmaceuticals distribution business." (9/29/2016)

  • FBR & Co analysts commented, "This morning, McKesson announced that it will combine most of its IT businesses with privately owned Change Healthcare (formerly known as Emdeon). MCK will own 70% of the new company and receive cash proceeds of $1.25 billion. MCK will continue to own the Relay Health Pharmacy operations and divest its Enterprise Information Solutions (EIS) division. The new company is expected to complete an IPO in the first half of CY17, and McKesson intends to exit its investment in the new company in a tax-efficient manner. We view the proposed transaction as a solid step to finally exiting the IT business, which the company entered in 1998. However, the ultimate impact on MCK will depend on how the new company is valued in the public equity markets and how MCK redeploys net proceeds from its potential sale." (6/29/2016)

Who owns McKesson stock?

McKesson's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (4.69%), FMR LLC (2.82%), Vulcan Value Partners LLC (1.63%), Scharf Investments LLC (0.49%), Institutional Capital LLC (0.48%) and Baupost Group LLC MA (0.47%). Company insiders that own McKesson stock include Erin M Lampert, James A Beer, John H Hammergren, Jorge Figueredo, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Paul C Julian, Susan R Salka and Wayne A Budd.

Who sold McKesson stock? Who is selling McKesson stock?

McKesson's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Southpoint Capital Advisors LP, Institutional Capital LLC, Franklin Resources Inc., Numeric Investors LLC, Martingale Asset Management L P, Teachers Retirement System of The State of Kentucky and AQR Capital Management LLC. Company insiders that have sold McKesson stock in the last year include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake and Wayne A Budd.

Who bought McKesson stock? Who is buying McKesson stock?

McKesson's stock was purchased by a variety of institutional investors in the last quarter, including Vulcan Value Partners LLC, Baupost Group LLC MA, Glenview Capital Management LLC, State Street Corp, Equity Investment Corp Acquisition Inc, Asset Management One Co. Ltd., Appaloosa LP and Russell Investments Group Ltd.. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka.

How do I buy McKesson stock?

Shares of McKesson can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of McKesson stock cost?

One share of McKesson stock can currently be purchased for approximately $150.85.

McKesson (NYSE:MCK) Chart for Saturday, February, 25, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Earnings History Chart

Earnings by Quarter for McKesson (NYSE:MCK)

Dividend History Chart

Dividend Payments by Quarter for McKesson (NYSE:MCK)

Last Updated on 2/25/2017 by Staff